• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cachexia as a common characteristic in multiple chronic disease.

作者信息

Scherbakov Nadja, Doehner Wolfram

机构信息

Department of Cardiology (CVK), Charité-Universitätsmedizin Berlin, Berlin, Germany.

Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Berlin, Germany.

出版信息

J Cachexia Sarcopenia Muscle. 2018 Dec;9(7):1189-1191. doi: 10.1002/jcsm.12388. Epub 2019 Jan 13.

DOI:10.1002/jcsm.12388
PMID:30637985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6351667/
Abstract
摘要

相似文献

1
Cachexia as a common characteristic in multiple chronic disease.恶病质是多种慢性疾病的共同特征。
J Cachexia Sarcopenia Muscle. 2018 Dec;9(7):1189-1191. doi: 10.1002/jcsm.12388. Epub 2019 Jan 13.
2
Casting the net broader to confirm our imaginations: the long road to treating wasting disorders.广泛撒网以验证我们的设想：治疗消耗性疾病的漫漫征途。
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):870-880. doi: 10.1002/jcsm.12256.
3
Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating PI3K/AKT/FoxO3a pathway.光生物调节疗法通过激活 PI3K/AKT/FoxO3a 通路调节癌症恶病质相关的肌肉减少症。
Apoptosis. 2024 Jun;29(5-6):663-680. doi: 10.1007/s10495-024-01949-2. Epub 2024 Apr 10.
4
Multimodal interventions for cachexia management.用于恶病质管理的多模式干预措施。
Cochrane Database Syst Rev. 2025 Mar 25;3(3):CD015749. doi: 10.1002/14651858.CD015749.pub2.
5
Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies.癌症恶病质中的肌肉减少症：临床意义、诊断和新兴治疗策略。
Annu Rev Med. 2011;62:265-79. doi: 10.1146/annurev-med-061509-131248.
6
Sarcopenia and cachexia in chronic diseases: from mechanisms to treatment.慢性疾病中的肌肉减少症和恶病质：从机制到治疗。
Pol Arch Intern Med. 2021 Dec 22;131(12). doi: 10.20452/pamw.16135. Epub 2021 Nov 15.
7
Cancer anorexia - cachexia syndrome.癌症厌食-恶病质综合征
Acta Med Indones. 2012 Apr;44(2):154-62.
8
Cancer Cachexia: Its Mechanism and Clinical Significance.癌症恶病质：发病机制及临床意义。
Int J Mol Sci. 2021 Aug 6;22(16):8491. doi: 10.3390/ijms22168491.
9
[Cachexia in chronic cardiac disease. Ancient syndrome new idea?].[慢性心脏疾病中的恶病质。古老综合征的新观点？]
Przegl Lek. 2006;63(3):151-4.
10
[Cardiac cachexia].[心脏恶病质]
Pol Arch Med Wewn. 2006 Jul;116(1):710-5.

引用本文的文献

1
A randomized controlled cross-over trial of differences in acute effects on serum metabolites from isocaloric meals based on red meat, fatty fish, or soy protein.一项关于基于红肉、富含脂肪的鱼类或大豆蛋白的等热量餐对血清代谢物急性影响差异的随机对照交叉试验。
Eur J Nutr. 2025 May 26;64(5):187. doi: 10.1007/s00394-025-03710-0.
2
Multimodal interventions for cachexia management.用于恶病质管理的多模式干预措施。
Cochrane Database Syst Rev. 2025 Mar 25;3(3):CD015749. doi: 10.1002/14651858.CD015749.pub2.
3
Relationship between sarcopenia and cachexia with prognostic markers of middle-aged and older inpatients with COVID-19: a case-control study.肌少症和恶液质与 COVID-19 中老年住院患者预后标志物的关系：一项病例对照研究。
Eur Geriatr Med. 2023 Jun;14(3):517-526. doi: 10.1007/s41999-023-00792-z. Epub 2023 May 10.
4
Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta-analysis.大麻素干预改善癌症恶病质结局的效果：系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):23-41. doi: 10.1002/jcsm.12861. Epub 2021 Dec 8.
5
Activation of the Complement System in Patients with Cancer Cachexia.癌症恶病质患者补体系统的激活。
Cancers (Basel). 2021 Nov 17;13(22):5767. doi: 10.3390/cancers13225767.
6
Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia.卡诺醇及其类似物可减轻癌症恶病质引起的肌肉萎缩和脂肪分解。
J Cachexia Sarcopenia Muscle. 2021 Jun;12(3):779-795. doi: 10.1002/jcsm.12710. Epub 2021 May 5.
7
Weight loss, malnutrition, and cachexia in COVID-19: facts and numbers.在 COVID-19 中体重减轻、营养不良和恶病质：事实与数据。
J Cachexia Sarcopenia Muscle. 2021 Feb;12(1):9-13. doi: 10.1002/jcsm.12674. Epub 2020 Dec 31.
8
Comment on: "Handgrip weakness, low fat-free mass, and overall survival in nonsmall cell lung cancer treated with curative-intent radiotherapy" by Burtin et al.对Burtin等人所著的《根治性放疗治疗非小细胞肺癌时的握力减弱、低去脂体重与总生存率》的评论
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1863-1864. doi: 10.1002/jcsm.12637.
9
Comment on 'Weight loss in heart failure is associated with increased mortality only in non-obese patients without diabetes' by Niedziela et al.对Niedziela等人所著的《心力衰竭患者体重减轻仅在无糖尿病的非肥胖患者中与死亡率增加相关》的评论
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1867-1868. doi: 10.1002/jcsm.12649. Epub 2020 Nov 26.
10
Targeting the JAK2/STAT3 Pathway-Can We Compare It to the Two Faces of the God Janus?靶向 JAK2/STAT3 通路——我们可以将其比作两面神雅努斯吗？
Int J Mol Sci. 2020 Nov 4;21(21):8261. doi: 10.3390/ijms21218261.

本文引用的文献

1
The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.结直肠癌患者接受手术治疗时，体成分、全身炎症反应与生存的关系：基于 CT 扫描的研究
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):111-122. doi: 10.1002/jcsm.12357. Epub 2018 Nov 20.
2
Host phenotype is associated with reduced survival independent of tumour biology in patients with colorectal liver metastases.结直肠肝转移患者的宿主表型与肿瘤生物学无关，与生存率降低有关。
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):123-130. doi: 10.1002/jcsm.12358. Epub 2018 Oct 31.
3
Experimental ischaemic stroke induces transient cardiac atrophy and dysfunction.实验性缺血性脑卒中可导致心脏一过性萎缩和功能障碍。
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):54-62. doi: 10.1002/jcsm.12335. Epub 2018 Oct 30.
4
Improved strength prediction combining clinically available measures of skeletal muscle mass and quality.结合临床可用的骨骼肌量和质量测量指标来改善力量预测。
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):84-94. doi: 10.1002/jcsm.12353. Epub 2018 Oct 29.
5
Cardiac expression of neutrophil gelatinase-associated lipocalin in a model of cancer cachexia-induced cardiomyopathy.中性粒细胞明胶酶相关脂质运载蛋白在癌症恶病质诱导性心肌病模型中的心脏表达。
ESC Heart Fail. 2019 Feb;6(1):89-97. doi: 10.1002/ehf2.12372. Epub 2018 Oct 26.
6
Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer.早期多模式干预对晚期胰腺和非小细胞肺癌老年患者的可行性。
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):73-83. doi: 10.1002/jcsm.12351. Epub 2018 Oct 18.
7
Do we need a reference standard for the muscle mass measurements?我们是否需要肌肉量测量的参考标准？
ESC Heart Fail. 2018 Oct;5(5):741-744. doi: 10.1002/ehf2.12356.
8
Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.在肝硬化患者中，腰大肌指数对预测等待名单死亡率高的患者的表现不佳。
J Cachexia Sarcopenia Muscle. 2018 Dec;9(6):1053-1062. doi: 10.1002/jcsm.12349. Epub 2018 Sep 29.
9
Repeatability of Dixon magnetic resonance imaging and magnetic resonance spectroscopy for quantitative muscle fat assessments in the thigh.Dixon 磁共振成像和磁共振波谱定量评估大腿肌肉脂肪的可重复性。
J Cachexia Sarcopenia Muscle. 2018 Dec;9(6):1093-1100. doi: 10.1002/jcsm.12343. Epub 2018 Sep 16.
10
Prevalence of rheumatoid cachexia in rheumatoid arthritis: a systematic review and meta-analysis.类风湿关节炎中类风湿恶病质的患病率：一项系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):816-825. doi: 10.1002/jcsm.12320. Epub 2018 Aug 21.